• Azilsartan Medoxomil: Assay-to-Outcome Design

  2026-08-19

  Azilsartan medoxomil monopotassium (TAK 491) connects selective AT1 receptor pharmacology with clinically meaningful blood-pressure endpoints. This guide presents an assay-to-outcome framework for hypertension, cardiovascular, and cardiorenal research.

• Bardoxolone methyl: Redox Signaling and Assay Design

  2026-08-19

  Explore how Bardoxolone methyl, also known as CDDO methyl ester, can be positioned in mechanistic oxidative stress research. This article connects Nrf2 and NF-kB biology with thioredoxin-dependent replication-stress assays while clearly separating established evidence from experimental hypotheses.

• CTP Solution for p21 mRNA-LNP Workflows

  2026-08-18

  Learn how a high-purity CTP Solution supports reproducible IVT mRNA production for lipid nanoparticle research, including localized p21 mRNA delivery models. The workflow combines controlled nucleotide handling, RNA quality checks, and assay-specific troubleshooting without confusing reagent performance with therapeutic efficacy.

• FerroOrange for Live-Cell Fe²⁺ Detection

  2026-08-18

  FerroOrange is a live-cell Fe²⁺ fluorescent probe for resolving intracellular ferrous-ion changes in microscopy, flow cytometry, and plate-based assays. This guide translates ferroptosis findings from ischemic-stroke research into practical assay designs, controls, optimization steps, and troubleshooting strategies.

• Ouabain: From Pump Blockade to Vascular Assays

  2026-08-17

  Ouabain is a selective Na+/K+-ATPase inhibitor with powerful applications in ion-transport and cardiovascular research. This guide explains how to connect pump inhibition, calcium handling, and vascular assay design while avoiding common interpretation errors.

• S Tag Peptide (A6007): Practical Workflow Guide

  2026-08-17

  S Tag Peptide is a short, highly soluble RNase A-derived peptide used to support recombinant protein detection, solubility improvement, and antibody-based purification when encoded as a fusion tag. It is suitable for aqueous or DMSO workflows, but not for ethanol-based solubilization, long-term storage of solutions, or use as an independently active ribonuclease reagent.

• Actinomycin D for AML mRNA Stability Assays

  2026-08-16

  Actinomycin D turns transcriptional arrest into a practical way to measure EPOR mRNA decay, transcriptional stress, and treatment-linked apoptosis in AML models. This workflow combines dose-controlled ActD exposure with IGF2BP3 perturbation to distinguish mRNA stability effects from nonspecific cytotoxicity.

• Trolox in Pancreatic Ductal Organoid Research

  2026-08-15

  Trolox can do more than benchmark antioxidant capacity: it can help dissect redox-dependent variability in pancreatic ductal organoid workflows. This article connects its chemistry with organoid initiation, lineage fidelity, oxidative injury research, and assay design limitations.

• Berberrubine chloride Research Workflows

  2026-08-14

  Berberrubine chloride supports mechanism-led workflows spanning IMPDH2-dependent colorectal cancer research, NSCLC chemosensitivity, urate metabolism, and inflammatory signaling. This guide translates reported activity into practical assay design, dosing logic, controls, and troubleshooting steps for reproducible research use.

• Everolimus (RAD001) in Reliable Cell Assays

  2026-08-14

  This scenario-based guide explains how Everolimus (RAD001), SKU A8169, can support more interpretable mTOR inhibition, proliferation, and cytotoxicity experiments. It connects mechanism, solvent handling, endpoint selection, dose interpretation, and supplier-quality criteria to practical laboratory decisions.

• Whole-Blood circUSP10 for Early NSCLC Diagnosis

  2026-08-13

  The reference study identified hsa_circ_0003026, termed circUSP10, as an elevated circular RNA in early-stage non-small-cell lung cancer and evaluated its detectability in whole blood. Its paired tissue-screening and blood-based validation strategy supports circUSP10 as a candidate minimally invasive biomarker, while also highlighting the need for larger, independent clinical validation.

• Tacrine Hydrochloride Hydrate in Translational AD Research

  2026-08-13

  Tacrine hydrochloride hydrate, also known as Tetrahydroaminacrine, remains a valuable mechanistic tool for connecting cholinergic biology with translational Alzheimer’s disease research. This article outlines how to use its pharmacology responsibly, validate assay performance, interpret metabolism-related findings, and design safer next-generation strategies.

• AmpliFold Capture-and-Release for Sensitive LFAs

  2026-08-12

  The AmpliFold strategy addresses a central limitation of lateral flow assays: insufficient time for analyte complexes to associate efficiently at a narrow test line. By capturing HER2 sandwich complexes across a broad surface, chemically releasing them, and rebinding them at a concentrated detection line, the study achieved up to 16-fold sensitivity improvement while retaining a rapid, equipment-free workflow.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-12

  The 2020 Cell Death & Differentiation study identifies the WNT5a/GSK3/β-catenin axis as a regulatory checkpoint that restrains adipogenic differentiation of skeletal-muscle fibro/adipogenic progenitors. By combining pharmacological inhibition, mass cytometry, mouse injury models, and transcriptomic network analysis, the authors connect impaired WNT5a signaling with fatty degeneration and altered support for muscle regeneration.

• Amikacin Sulfate: Reliable Assay Workflows

  2026-08-11

  Learn how Amikacin Sulfate, SKU C8696, can improve the interpretation and reproducibility of antimicrobial, intracellular infection, and mammalian-cell compatibility experiments. This scenario-driven guide connects concentration selection, assay controls, storage, and vendor evaluation to published and product-dossier evidence.

16784 records 1/1119 page Next 12345 下5页 Last page